Your browser doesn't support javascript.
loading
A Platinum Resistance-Related lncRNA Signature for Risk Classification and Prognosis Prediction in Patients with Serous Ovarian Cancer.
Zhu, Yan; Chen, Jiongyu; Zhou, Li; Zhang, Lina; Liu, Yuxin; Zhuang, Yixuan; Peng, Lin; Huang, Yi-Teng.
Affiliation
  • Zhu Y; Health Care Center, The First Affiliated Hospital of Shantou University Medical College, Shantou 515041, Guangdong, China.
  • Chen J; Medical Laboratory, Shenzhen Luohu People's Hospital, Shenzhen 518001, Guangdong, China.
  • Zhou L; Central Laboratory, Cancer Hospital of Shantou University Medical College, Shantou 515041, Guangdong, China.
  • Zhang L; Department of Gynecologic Oncology, Cancer Hospital of Shantou University Medical College, Shantou 515041, Guangdong, China.
  • Liu Y; Health Care Center, The First Affiliated Hospital of Shantou University Medical College, Shantou 515041, Guangdong, China.
  • Zhuang Y; Health Care Center, The First Affiliated Hospital of Shantou University Medical College, Shantou 515041, Guangdong, China.
  • Peng L; Department of Pathology, Cancer Hospital of Shantou University Medical College, Shantou 515041, Guangdong, China.
  • Huang YT; Central Laboratory, Cancer Hospital of Shantou University Medical College, Shantou 515041, Guangdong, China.
J Oncol ; 2022: 7625138, 2022.
Article in En | MEDLINE | ID: mdl-37223641

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: J Oncol Year: 2022 Document type: Article Affiliation country: China Country of publication: Egypt

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: J Oncol Year: 2022 Document type: Article Affiliation country: China Country of publication: Egypt